These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7596498)

  • 1. Medulloblastoma and Collins' law: a critical review of the concept of a period of risk for tumor recurrence and patient survival.
    Brown WD; Tavaré CJ; Sobel EL; Gilles FH
    Neurosurgery; 1995 Apr; 36(4):691-7. PubMed ID: 7596498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collins' law. Prediction of recurrence or cure in childhood medulloblastoma?
    Sure U; Berghorn WJ; Bertalanffy H
    Clin Neurol Neurosurg; 1997 May; 99(2):113-6. PubMed ID: 9213055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The applicability of Collins' Law to childhood brain tumors and its usefulness as a predictor of survival.
    Brown WD; Tavaré CJ; Sobel EL; Gilles FH
    Neurosurgery; 1995 Jun; 36(6):1093-6. PubMed ID: 7643986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence of medulloblastoma: violation of Collins' law after two decades.
    Friedberg MH; David O; Adelman LS; Heilman CB
    Surg Neurol; 1997 Jun; 47(6):571-4. PubMed ID: 9167782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medulloblastoma. Period of risk reviewed.
    Latchaw JP; Hahn JF; Moylan DJ; Humphries R; Mealey J
    Cancer; 1985 Jan; 55(1):186-9. PubMed ID: 3965079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based study of medulloblastoma: outcomes in Alberta from 1975 to 1996.
    Roldán G; Brasher P; Vecil G; Senger D; Rewcastle B; Cairncross G; Forsyth P; Hamilton M
    Can J Neurol Sci; 2008 May; 35(2):210-5. PubMed ID: 18574936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medulloblastoma: survival and late recurrence after the Collins' risk period.
    Nishio S; Morioka T; Takeshita I; Fukui M
    Neurosurg Rev; 1997; 20(4):245-9. PubMed ID: 9457719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medulloblastoma in pediatric age: a single-institution review of prognostic factors.
    Cervoni L; Cantore G
    Childs Nerv Syst; 1995 Feb; 11(2):80-4; discussion 85. PubMed ID: 7758016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma.
    Bowers DC; Gargan L; Weprin BE; Mulne AF; Elterman RD; Munoz L; Giller CA; Winick NJ
    J Neurosurg; 2007 Jul; 107(1 Suppl):5-10. PubMed ID: 17644914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late recurrence of primitive neuroectodermal tumor/medulloblastoma.
    Lefkowitz IB; Packer RJ; Ryan SG; Shah N; Alavi J; Rorke LB; Sutton LN; Schut L
    Cancer; 1988 Aug; 62(4):826-30. PubMed ID: 2840194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival Following Tumor Recurrence in Children With Medulloblastoma.
    Johnston DL; Keene D; Strother D; Taneva M; Lafay-Cousin L; Fryer C; Scheinemann K; Carret AS; Fleming A; Afzal S; Wilson B; Bowes L; Zelcer S; Mpofu C; Silva M; Larouche V; Brossard J; Bouffet E
    J Pediatr Hematol Oncol; 2018 Apr; 40(3):e159-e163. PubMed ID: 29432312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.
    Stensvold E; Krossnes BK; Lundar T; Due-Tønnessen BJ; Frič R; Due-Tønnessen P; Bechensteen AG; Myklebust TÅ; Johannesen TB; Brandal P
    Acta Oncol; 2017 May; 56(5):698-705. PubMed ID: 28325133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late recurrence in medulloblastoma.
    King GA; Sagerman RH
    Am J Roentgenol Radium Ther Nucl Med; 1975 Jan; 123(1):7-12. PubMed ID: 1119661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medulloblastoma: freedom from relapse longer than 8 years--a therapeutic cure?
    Belza MG; Donaldson SS; Steinberg GK; Cox RS; Cogen PH
    J Neurosurg; 1991 Oct; 75(4):575-82. PubMed ID: 1885975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medulloblastoma in children--the Ottawa experience.
    Modha A; Vassilyadi M; George A; Kuehn S; Hsu E; Ventureyra EC
    Childs Nerv Syst; 2000 Jun; 16(6):341-50. PubMed ID: 10933229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medulloblastoma: clinical presentation and management. Experience at the hospital for sick children, toronto, 1950-1980.
    Park TS; Hoffman HJ; Hendrick EB; Humphreys RP; Becker LE
    J Neurosurg; 1983 Apr; 58(4):543-52. PubMed ID: 6827349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of radiosurgery in the management of recurrent and residual medulloblastoma.
    Patrice SJ; Tarbell NJ; Goumnerova LC; Shrieve DC; Black PM; Loeffler JS
    Pediatr Neurosurg; 1995; 22(4):197-203. PubMed ID: 7619720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medulloblastoma.
    Zhang R; Zhou L
    Chin Med J (Engl); 1999 Apr; 112(4):297-301. PubMed ID: 11593525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medulloblastoma in children. Twenty-two years' experience with radiation therapy.
    Aron BS
    Am J Dis Child; 1971 Apr; 121(4):314-7. PubMed ID: 5550736
    [No Abstract]   [Full Text] [Related]  

  • 20. Medulloblastoma: is the 5-year survival rate improving? A review of 80 cases from a single institution.
    David KM; Casey AT; Hayward RD; Harkness WF; Phipps K; Wade AM
    J Neurosurg; 1997 Jan; 86(1):13-21. PubMed ID: 8988076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.